On April 15, 2025, the Hong Kong stock market closed with mixed results. The Hang Seng Index rose by 0.23%, while the Hang Seng Tech Index fell by 0.67%.
DualityBio-B surged by an impressive 116.70%, driven by positive clinical trial results for its new cancer treatment, which showed promising efficacy and safety profiles.
Zenergy rose by 6.08%, following the announcement of a major contract win for renewable energy projects in Southeast Asia.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。